Dysfunctional Uterine Bleeding

Dysfunctional uterine bleeding (DUB) is defined as abnormal uterine bleeding that results from an ovarian endocrinopathy. It may be associated with ovulatory and anovulatory cycles. The diagnosis of DUB depends on a thorough history and physical examination to exclude organic disorders. In older women, endometrial biopsy should be done before starting therapy. The treatment depends on an understanding of the menstrual cycle. In less urgent cases, anovulatory cycles are managed using progesterone replacement, and ovulatory cycles respond well to non-steroidal anti-inflammatory drugs (NSAIDs). In urgent cases oral or intravenous estrogen is used, and emergency dilation and currettage are done if the hemorrhage fails to stop.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (964K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

• Fayez JA. Dysfunctional uterine bleeding. Am Fam Physician. 1982 Mar; 25 (3):109–115. [PubMed] [Google Scholar]
• Skjodt P, Albrechtsen OK. Coagulation and fibrinolysis in uterine blood. Acta Obstet Gynecol Scand. 1965; 44 (3):416–436. [PubMed] [Google Scholar]
• Fraser IS, Michie EA, Wide L, Baird DT. Pituitary gonadotropins and ovarian function in adolescent dysfunctional uterine bleeding. J Clin Endocrinol Metab. 1973 Sep; 37 (3):407–414. [PubMed] [Google Scholar]
• Van Look PF. Failure of positive feedback. Clin Obstet Gynaecol. 1976 Dec; 3 (3):555–578. [PubMed] [Google Scholar]
• Downie J, Poyser NL, Wunderlich M. Levels of prostaglandins in human endometrium during the normal menstrual cycle. J Physiol. 1974 Jan; 236 (2):465–472. [PMC free article] [PubMed] [Google Scholar]
• Willman EA, Collins WP, Clayton SG. Studies in the involvement of prostaglandins in uterine symptomatology and pathology. Br J Obstet Gynaecol. 1976 May; 83 (5):337–341. [PubMed] [Google Scholar]
• Boyd ME. Dysfunctional uterine bleeding. Can J Surg. 1986 Sep; 29 (5):305–307. [PubMed] [Google Scholar]
• Chimbira TH, Anderson AB, Turnbull A c. Relation between measured menstrual blood loss and patient's subjective assessment of loss, duration of bleeding, number of sanitary towels used, uterine weight and endometrial surface area. Br J Obstet Gynaecol. 1980 Jul; 87 (7):603–609. [PubMed] [Google Scholar]
• Hallberg L, Högdahl AM, Nilsson L, Rybo G. Menstrual blood loss--a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand. 1966; 45 (3):320–351. [PubMed] [Google Scholar]
• Guillebaud J, Barnett MD, Gordon YB. Plasma ferritin levels as an index of iron deficiency in women using intrauterine devices. Br J Obstet Gynaecol. 1979 Jan; 86 (1):51–55. [PubMed] [Google Scholar]
• Worley RJ. Dysfunctional uterine bleeding. Clarifying its definition, mechanisms, and management. Postgrad Med. 1986 Feb 15; 79 (3):101–106. [PubMed] [Google Scholar]
• Grimes DA. Diagnostic dilation and curettage: a reappraisal. Am J Obstet Gynecol. 1982 Jan 1; 142 (1):1–6. [PubMed] [Google Scholar]
• Brown KL. The treatment of osteogenic sarcoma. Can J Surg. 1986 Jan; 29 (1):5–6. [PubMed] [Google Scholar]
• Fraser IS. Treatment of dysfunctional uterine bleeding with danazol. Aust N Z J Obstet Gynaecol. 1985 Aug; 25 (3):224–226. [PubMed] [Google Scholar]
• Fraser IS, Pearse C, Shearman RP, Elliott PM, McIlveen J, Markham R. Efficacy of mefenamic acid in patients with a complaint of menorrhagia. Obstet Gynecol. 1981 Nov; 58 (5):543–551. [PubMed] [Google Scholar]
• DeVore GR, Owens O, Kase N. Use of intravenous Premarin in the treatment of dysfunctional uterine bleeding--a double-blind randomized control study. Obstet Gynecol. 1982 Mar; 59 (3):285–291. [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada